BRCA1- and BRCA2-deficient ovarian cancers in an unselected cohort of ovarian cancer patients were also shown to have increased PD-L1 and PD-1 expression compared to BRCA-proficient ovarian cancers. This evidence concerns the gene CD274 and ovarian carcinoma.